Medicine
Cromolyn 20 mg/2 mL solution
Cromolyn 20 mg/2 mL solution is a generic prescription medicine for intrabronchial use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). PROTECT FROM LIGHT.
Key facts
- Active ingredient (INN)
- Cromolyn
- Brand
- Sold under the generic name
- Strength
- 20 mg/2 mL
- Dosage form
- Solution
- Route
- Intrabronchial
- Packs
- 12 pouches
- Manufacturer
- Teva Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). PROTECT FROM LIGHT.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A07EB01 Cromolyn
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 18 January 2000
- Identifiers
- RxCUI 831246DailyMed set ID 8fe37a7a-edd6-4733-bb7e-e01c1906aebaNDC 0172-6406Application ANDA075271
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 12 pouch in 1 carton / 5 vial, single-dose in 1 pouch / 2 mL in 1 vial, single-dose | 0172-6406-49 | Teva Pharmaceuticals | 18 January 2000 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 28 May 1982 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Cromolyn
Clinical summary
Cromolyn is a mast cell stabilizer indicated in the management of patients with mastocytosis. It is available as eye drops, oral concentrate and oral liquid for ophthalmic and intrabronchial use. MedsAcross supplies Cromolyn for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CromolynFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Gastrocrom prescribing information (Viatris Specialty) · U.S. National Library of Medicine, DailyMed
Need Cromolyn 20 mg/2 mL solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.